Please join Greenberg Traurig and Exponent for Medical Devices, Market Trends & Opportunities – Educational Breakfast on Tuesday, November 12th, from 7:30 AM to 10:30 AM at the law firm of Greenberg Traurig located at One International Place, Suite 2000, in Boston, Massachusetts.

This educational breakfast will address the trends in the MedTech industry, identify the opportunities for innovators to develop IP, examine the energy and power management for medical devices, and develop understanding on requirements and constraints that originate from patients, physicians, and regulatory agencies.

AGENDA

7:30 – 8:00 AM Breakfast and Networking

8:00 – 9:30 AM Panel Discussion

• Geoff DaCosta
• David Dykman
• Dr. David Borsook, M.D
• Dr. Alexander Margulis, Ph.D.

9:45 – 10:30 AM Presentations:

• Quinn C. Horn, Ph.D., P.E. – Battery Selection for Medical Devices
• Sergio Mendoza, Ph.D. – System Requirements for Battery Powered Medical Devices

SPEAKERS

Quinn C. Horn, Ph.D., P.E., Principal, Exponent

Dr. Horn has over 20 years of experience solving complex battery safety problems.  Prior to joining Exponent in 2004, Dr. Horn led the failure analysis group at Energizer/Eveready Battery Company, where he conducted failure analysis studies on a wide variety of commercial battery systems including lithium-ion, lithium-primary, nickel-metal hydride, nickel cadmium, lead-acid, and alkaline primary cells. He is a Research Affiliate at the Massachusetts Institute of Technology, where he collaborates with researchers in the Electrochemical Energy Laboratory.

David Dykeman, Shareholder, Greenberg Traurig

David Dykeman, who co-chairs the firm’s global Life Sciences & Medical Technology Group, is a registered patent attorney with more than 20 years of experience in patent and intellectual property law. David’s practice focuses on securing worldwide intellectual property protection and related business strategy for high tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology. David provides strategic patent portfolio development and intellectual property advice for clients including major research institutions, multi-national corporations, and start-up companies.

Geoff DaCosta, Director of Business Development & Licensing, Medtronic

Geoff DaCosta is currently a Director of Business Development and Licensing within the Surgical Innovations business of Medtronic, where he coordinates strategic partnership and M&A activities. Geoff joined Medtronic in 2015 following its acquisition of Covidien PLC.  He started with Covidien in 2008, serving in various roles, including Director of Strategy and Business Development within the Vascular Therapies business. Previously, he worked in the Transaction Advisory Services group of Ernst & Young, as well as multiple Boston boutique advisory firms. Geoff holds an MBA from the UCLA Anderson School of Management and a BA in Economics from the University of Pennsylvania.

Alex Margulis, Ph.D., Chief Operating Officer, Mansfield Bio-Incubator

Dr. Margulis is currently leveraging his scientific and business acumen to manage the operations and business development at Mansfield Bio-Incubator. Concurrently, he is working as a Business Development Manager (New England) in a boutique life science and marketing strategy organization. Previously, while working at Precision Biosystems where he developed and executed a strategy to increase the sales by 100% within 1 year while managing a team of manufacturer’s representatives. Beforehand, he worked as a Senior Scientist at BIOARRAY Therapeutics, where he managed the project to set up a fully functional laboratory 33% ahead of schedule while saving money and developed proof-of-concept assays for the company’s leading diagnostic test.

David Borsook, MD, PhD, Professor, Harvard Medical School

Dr. Borsook is a Professor at Harvard Medical School.  He has a background in Neurology (MD) and Neurobiology (PhD) and an interest in transferring new technologies into the biotech space. Aside from research focus, he had a long clinical involvement in pain medicine at MGH, including being the Director of Pain Medicine at the institution.  He has published nearly 300 articles in peer reviewed journals. His Research Program – The Center for Pain and the Brain – at  Boston Children’s, Massachusetts General and McLean Hospitals evaluates brain and nerve markers of pain and analgesics. He has authored a number of patents, was the Chief Scientific Officer of a Biotech he founded and has licensed IP to industry.

Sergio Mendoza, Ph.D., Senior Associate, Exponent

Dr. Mendoza is a system engineer who builds on his controls background to perform multi-level analysis on electrified systems pertaining to different industries including automotive, medical and consumer electronics. His areas of expertise include optimal design of experiments to minimize the cost of experimentation while maximizing the statistical meaning of the data collected; model-based energy, power and thermal control of battery powered systems, and estimation of the lifetime of lithium-ion cells. Furthermore, Dr. Mendoza applies his extensive knowledge of lithium-ion cells and systems background to conduct Design Failure Mode and Effects Analysis (DFMEA) and safety analyses including Preliminary Hazard Analyses (PHA).